Simulations Plus Corp (SLP) - Biznesning o‘zini qoplash muddati

Simulations Plus Inc - SLP emitenti grafik logotipi

Asosiy baholash vositasi bo'lib xizmat qiluvchi, 46.70 indikatoriga ega ushbu Simulations Plus, Inc. (SLP) narxlar grafigi jismoniy kimyoviy namunalarni minimallashtiruvchi biofarmatsevtika modellarining ekologik ahamiyatini ta'kidlaydi. Biznes reagentlar xarajatlarini optimallashtiradigan va marjalarni mustahkamlovchi klinikadan oldingi virtualizatsiya dasturiy ta'minotiga tayanadi. Kapital barqarorligi avtonom dori ishlab chiqish sikli orqali kafolatlanadi, bu esa aktivni global bozor sharoitlaridan qat'i nazar, chidamli himoya mexanizmiga aylantiradi.

Narx-foyda koeffitsiyenti: Simulations Plus, Inc. (SLP) 04.07.2022 - 18.10.2026 uchun

Simulations Plus Corp (SLP) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning umumiy tahlili:simulations-plus.com, SLP
Simulations Plus Corp brendining mahsuloti

P/E koeffitsiyenti Simulations Plus, Inc. (SLP) kompaniyasining bozor qiymatini uning sof foydasiga nisbatan aks ettiradi va daromadning har bir birligi uchun xarajatni o'lchaydi. Koeffitsiyentning o'sishi yuqori rentabellik kutayotganini anglatadi, kamayishi esa aktivlarning qadrsizlanganiga ishora qiladi. Simulations Plus, Inc. (SLP) kompaniyasining tarixiy P/E dinamikasini tahlil qilish orqali investor biznesning haddan tashqari yuqori baholangan davrlarini aniqlashi mumkin. Ushbu koeffitsiyentning barqarorligi biosimulyatsiya sektoridagi keng mijozlar bazasi bilan ta'minlanadi, bu esa foydaning alohida hamkorlarning patent risklariga bog'liqligini minimallashtiradi.

Muhim raqobatchilar

veeva.com (VEEV) - Biznesning o‘zini qoplash muddati|P/E multiplikatori DOCS|Biznesning o‘zini qoplash muddati HealthEquity Inc|Narxning foydaga nisbati Waystar Inc. WAY|CRVL - Narx-foyda koeffitsiyenti|PRVA: Narx-foyda koeffitsiyenti|HURN - P/E multiplikatori|Certara (CERT) - Narxning foydaga nisbati|OMCL (Omnicell Inc) - Narxning foydaga nisbati|GDRX (GoodRx Corp) - P/E multiplikatori|P/E multiplikatori Schrodinger Corp|Narx-foyda koeffitsiyenti PHR (Phreesia, Inc.)|Bozor narxining sof foydaga nisbati OMDA|P/E multiplikatori EVH (Evolent Health)|Biznesning o‘zini qoplash muddati HealthStream Inc (HSTM)|DH - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Consensus Corp|Agilon Health (AGL) - Narxning foydaga nisbati|Narx-foyda multiplikatori ABSI|Narxning foydaga nisbati So-Young International Inc.|National Research Corp (NRC) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti SPOK (Spok Corp)|OPRX (OptimizeRx Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati TruBridge, Inc. TBRG|SOPH (Sophia Genetics) - Kapitalizatsiyaning sof foydaga nisbati|HCAT - Narxning foydaga nisbati|CCLD: Narxning foydaga nisbati|RSSS (Research Solutions, Inc.) - Narx-foyda koeffitsiyenti|DLH Holdings (DLHC) - P/E multiplikatori|Narxning foydaga nisbati OneMedNet Corp|scienture.com (SCNX) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti HCTI (Healthcare Triangle, Inc.)|ISPC (ispecimen.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BFRG (Bullfrog AI)|Biznesning o‘zini qoplash muddati SCWorx Inc (WORX)|MSPR - Narxning foydaga nisbati|ICCT (iCoreConnect Inc.) - Narx-foyda multiplikatori|MEDS: P/E multiplikatori|Narx-foyda koeffitsiyenti Orgenesis Inc|Narx-foyda koeffitsiyenti RCM|Sharecare Inc (SHCR) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Streamline Health Solutions (STRM)|Biznesning o‘zini qoplash muddati syrahealth.com|Narxning foydaga nisbati Apollo Medical Holdings, Inc. AMEH|Model N Inc - Narxning foydaga nisbati|NXGN - Narxning foydaga nisbati